Status:

UNKNOWN

Effect of Right Bifocal Ventricular Cardiac Pacing on Serum Level Natriuretic Peptides in Patients With Heart Failure

Lead Sponsor:

Instituto Dante Pazzanese de Cardiologia

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this study we will select twenty patients with chronic atrial fibrillation and ventricular dysfunction with permanent cardiac pacemaker indication. We will dosage serum level natriuretic peptides f...

Detailed Description

The target study population will comprise patients with permanent atrial fibrillation with mild or moderate myocardial dysfunction according to the American consensus echocardiography and the classica...

Eligibility Criteria

Inclusion

  • Permanent atrial fibrillation with bradycardia and classic indication for permanent pacemaker
  • mild or moderate ventricular dysfunction (35% \<left ventricle ejection fraction \<55%) of any etiology
  • Signature of the free and informed consent

Exclusion

  • Age \<18 years
  • left ventricle ejection fraction \> 55% or ≤ 35%
  • classic indication of cardiac resynchronization therapy by Brazilian Guidelines for Cardiac Implantable Electronic Devices
  • Patients with left ventricle ejection fraction ≤ 35%, with permanent atrial fibrillation, heart failure with functional class III or IV despite optimal pharmacological treatment and QRS\> 150 ms
  • Patients with left ventricle ejection fraction ≤ 35%, with permanent atrial fibrillation, heart failure with functional class III or IV despite optimal pharmacological treatment and QRS 120-150 ms with evidence of dyssynchrony by imaging method
  • Patients with indication for pacemaker when ventricular pacing is essential, left ventricle ejection fraction ≤ 35% and heart failure with functional class III or IV
  • Refusal to signing the informed consent

Key Trial Info

Start Date :

February 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2017

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT02186314

Start Date

February 1 2014

End Date

February 1 2017

Last Update

August 3 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Carolina Christianini Mizzaci

São Paulo, São Paulo, Brazil, 04012909